You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult lymphomas

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

Not yet recruiting
  • Advanced Malignancies
  • 1A46 Drug Substance
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 4, 2023

Collection of Tissue Samples for Cancer Research

Recruiting
  • Neoplasms
  • +3 more
  • Biopsy
  • Atlanta, Georgia
  • +9 more
Jan 23, 2023

DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Aug 22, 2022

Tumors, Lymphoma Trial run by the National Cancer Institute (NCI) (LMP400, LMP776)

Completed
  • Neoplasms
  • Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    Different Sonographic Modalities and PET-CT in Pediatric

    Not yet recruiting
    • Pediatric Lymphoma
    • ultrasonography
    • (no location specified)
    Apr 22, 2022

    Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

    Recruiting
    • Lymphoma, B-Cell
    • Chronic Lymphocytic Leukemia
    • Chicago, Illinois
    • +8 more
    Jun 21, 2022

    Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

    Recruiting
    • Newly Diagnosed Peripheral T-cell Lymphoma
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Jun 1, 2023

    Advanced Solid Tumors, Lymphomas Trial in Tiong Bahru (Alisertib)

    Completed
    Has Results
    • Advanced Solid Tumors
    • Lymphomas
    • Tiong Bahru, Singapore
      National Cancer Centre
    Nov 29, 2018

    T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • CD7 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 11, 2022

    Extranodal Lymphoma or Lymphoma of Rare Pathological Types

    Not yet recruiting
    • Lymphoma
    • +8 more
    • No interventions need to be specified for this study
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jun 15, 2023

    Tumors Malignant Trial in Shanghai (AK117)

    Active, not recruiting
    • Neoplasms Malignant
    • Shanghai, Shanghai, China
      FuDan University Shanghai Cancer Center
    Oct 8, 2022

    Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • Non-Hodgkin Lymphoma
    • San Antonio, Texas
      NEXT Oncology
    Jan 6, 2023

    Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston

    Recruiting
    • Refractory B-Cell Non-Hodgkin Lymphoma
    • +4 more
    • CD19.CAR-aNKT cells
    • +2 more
    • Houston, Texas
    • +1 more
    Aug 19, 2022

    B-Cell Malignancies Trial in Canton, Houston (TT-01488)

    Recruiting
    • B-Cell Malignancies
    • Canton, Ohio
    • +1 more
    Jun 8, 2022

    Tisagenlecleucel in Brazilian Acute Lymphoblastic Leukemia or

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • Acute Lymphoblastic Leukemia
    • tisagenlecleucel
    • (no location specified)
    Sep 13, 2022

    Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

    Not yet recruiting
    • Mycosis Fungoides of Skin (Diagnosis)
    • +5 more
    • Med-Jet Injector
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 17, 2023

    Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

    Not yet recruiting
    • Adult T-cell Leukemia/Lymphoma
    • +4 more
    • CC-486 (5-azacitidine)
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Lymphoma, Large B-Cell, Diffuse, Fatigue Trial in Columbus (Fatigue Reduction Diet)

    Completed
    • Lymphoma, Large B-Cell, Diffuse
    • Fatigue
    • Fatigue Reduction Diet
    • Columbus, Ohio
      The Ohio State University
    Apr 26, 2022

    Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

    Completed
    • Solid Tumor
    • Lymphoma
    • MK-2118 (IT)
    • +2 more
    • La Jolla, California
    • +7 more
    Jan 23, 2023

    Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

    Recruiting
    • Neoplasms
    • +2 more
    • La Jolla, California
    • +15 more
    Dec 7, 2022

    NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

    Recruiting
    • Advanced Solid Tumors or Lymphomas
    • Changsha, Hunan, China
      Hunan Provincal Tumor Hospital
    Oct 5, 2023

    Minimal Residual Disease in Peripheral T-cell Lymphoma

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Tumor biopsy
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Dec 19, 2022

    Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Brentuximab Vedotin
    • +2 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022